v3.25.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Nov. 30, 2020
Current assets:              
Cash and cash equivalents $ 322,399 $ 578,157 $ 573,171 $ 574,962      
Accounts receivable, net 38,520 28,788 34,742 54,605      
Inventory 50,082 50,534 49,343 51,397      
Prepaid expenses and other current assets 18,145 21,659 17,063 18,948      
Total current assets 429,146 679,138 681,502 699,912      
Property and equipment, net 164,474 164,555 165,503 162,900      
Goodwill 159,878 171,790 326,029 326,029      
Intangible assets, net 194,957 201,858 207,249 220,987      
Other assets 59,789 60,914 63,465 77,622      
Total assets 1,008,244 1,278,255 1,443,748 1,487,450      
Current liabilities:              
Accrued expenses and other current liabilities 36,407 38,898 40,719 60,237      
Deferred revenue 2,375 1,902 2,146 3,360      
Current portion of long-term debt 5,440 5,440 5,440 5,440      
Current portion of finance lease liabilities 792 750 710 633      
Total current liabilities 56,971 63,709 68,620 87,468      
Long-term debt, less current portion 290,492 516,283 517,083 518,707      
Finance lease liabilities, less current portion 31,106 31,327 31,527 31,897      
Other long-term liabilities 52,466 54,237 54,032 59,494      
Total liabilities 431,035 665,556 671,262 697,566      
Commitments and contingencies (Note 9)      
Stockholders’ equity:              
Additional paid-in capital 181,874 175,579 168,337 128,503      
Retained earnings 140,891 166,796 263,870 285,737      
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc. 325,292 344,898 434,729 416,753      
Non-controlling interest 251,917 267,801 337,757 373,131      
Total stockholders’ equity 577,209 612,699 772,486 789,884 $ 905,243 $ 545,361  
Total liabilities and stockholders’ equity 1,008,244 1,278,255 1,443,748 1,487,450      
Class A Common Stock              
Stockholders’ equity:              
Common stock $ 1,420 $ 1,416 $ 1,415 $ 1,322      
Common stock, shares authorized (in shares) 500,000,000 500,000,000 500,000,000 500,000,000     500,000,000
Shares of Class B common stock              
Stockholders’ equity:              
Common stock $ 1,107 $ 1,107 $ 1,107 $ 1,191      
Common stock, shares authorized (in shares) 256,856,000 256,856,000 256,856,000 300,000,000     300,000,000
Nonrelated Party              
Current liabilities:              
Accounts payable $ 11,957 $ 9,494 $ 12,536 $ 10,729      
Related Party              
Current liabilities:              
Accounts payable $ 0 $ 7,225 $ 7,069 $ 7,069      

Source

HTML PDF
ZIP